SCHEMBL4703290

SCHEMBL4703290

CCOc1cc(CN(c2nc(O)c3ccccc3n2)C2CCNCC2)ccc1Cl

nearest known ligand 0.46

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 13/20 0.46
SLC6A4 P31645 13/20 0.46
SLC6A3 Q01959 12/20 0.46
SSTR5 P35346 1/20 0.38
HRH1 P35367 1/20 0.38
HTR2B P41595 1/20 0.38
KCNH2 Q12809 2/20 0.38
MGLL Q99685 1/20 0.38
CHEK2 O96017 1/20 0.36
TACR1 P25103 2/20 0.35
HTR6 P50406 1/20 0.35
HIF1A Q16665 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4702470 0.82 SLC6A4 (0.48) SLC6A2SLC6A4SLC6A3SSTR5HRH1
SCHEMBL5558707 0.78 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3SSTR5HRH1
SCHEMBL4701211 0.78 SLC6A4 (0.44) SLC6A2SLC6A4SLC6A3SSTR5HRH1
SCHEMBL4700592 0.76 SLC6A4 (0.41) SLC6A2SLC6A4SLC6A3SSTR5HRH1
SCHEMBL4706328 0.75 SLC6A4 (0.44) SLC6A2SLC6A4SLC6A3SSTR5HRH1
SCHEMBL3927956 0.75 SLC6A4 (0.39) SLC6A2SLC6A4SLC6A3SSTR5HRH1
SCHEMBL4706291 0.75 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3SSTR5HRH1
SCHEMBL3973823 0.75 SLC6A4 (0.40) SLC6A2SLC6A4SLC6A3SSTR5HRH1
SCHEMBL5488867 0.74 SSTR5 (0.38) SLC6A2SLC6A4SLC6A3SSTR5HRH1
SCHEMBL5564397 0.74 SLC6A2 (0.47) SLC6A2SLC6A4SLC6A3HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2001867-A2 PYRIMIDINE, QUINAZOLINE, PTERIDINE AND TRIAZINE DERIVATIVES F. Hoffmann-Roche AG (CH) 2008-12-17 EP disclosed
WO-2007110340-A2 PYRIMIDINE, QUINAZOLINE, PTERIDINE AND TRIAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-10-04 WO disclosed